Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Alutard SQ Dog in Dog Allergic Patients
NCT07651891Phase 4Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Dog Allergen Extract in dog allergy, sponsored by Karolinska Institutet. Primary endpoint: Total Nasal Symptom Score at 1 year. Started Aug 2026; status: recruiting.
02
Drugs
Dog Allergen Extract
03
Conditions
dog allergy
Beyond the preview
Go deeper on NCT07651891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07651891.